Back to Journals » Drug Design, Development and Therapy
Drug Design, Development and Therapy
ISSN: 1177-8881
An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (4186)
- Volume 18, 2024 (147)
- Volume 17, 2023 (283)
- Volume 16, 2022 (316)
- Volume 15, 2021 (399)
- Volume 14, 2020 (477)
- Volume 13, 2019 (387)
- Volume 12, 2018 (382)
- Volume 11, 2017 (330)
- Volume 10, 2016 (374)
- Volume 9, 2015 (543)
- Volume 8, 2014 (231)
- Volume 7, 2013 (143)
- Volume 6, 2012 (42)
- Volume 5, 2011 (40)
- Volume 4, 2010 (35)
- Volume 3, 2009 (27)
- Volume 2, 2008 (29)
- Volume 1, 2007 (1)
Latest articles:
- 5 records -
Development of Intratumoral Drug Delivery Based Strategies for Antitumor Therapy
Jiang Z, Fu Y, Shen H
Drug Design, Development and Therapy 2024, 18:2189-2202
Published Date: 11 June 2024
Integrating Network Pharmacology and Experimental Validation to Decipher the Mechanism of Action of Astragalus–Atractylodes Herb Pair in Treating Hepatocellular Carcinoma
Liang Y, Xie Y, Liu X, Yu L, Yan H, Shang Z, Wu Y, Cai X, Shi W, Du J, Yang Z
Drug Design, Development and Therapy 2024, 18:2169-2187
Published Date: 11 June 2024
Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs
Zhao H, Liu Y, Cai N, Liao X, Tang L, Wang Y
Drug Design, Development and Therapy 2024, 18:2143-2167
Published Date: 11 June 2024
Benzoylaconine Protects Skeletal Muscle Against Ischemia-Reperfusion Injury Through Activation of IF1-Dependent AMPK/Nrf2 Axis
Cui Y, Liu Q, Zhang Q, Di X, Zhang H
Drug Design, Development and Therapy 2024, 18:2125-2142
Published Date: 10 June 2024
Extracellular Vesicles Derived from H2O2-Stimulated Adipose-Derived Stem Cells Alleviate Senescence in Diabetic Bone Marrow Mesenchymal Stem Cells and Restore Their Osteogenic Capacity
Li Y, Yue G, Yu S, Liu Z, Cao Y, Wang X
Drug Design, Development and Therapy 2024, 18:2103-2124
Published Date: 10 June 2024